Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

NCT00414661 ·Status: COMPLETED

An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.

NCT02590562 ·Status: COMPLETED

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

NCT02804204 ·Status: UNKNOWN

Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France

NCT02927509 ·Status: COMPLETED

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

NCT01557322 ·Status: COMPLETED

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis

NCT00596206 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain

NCT00881881 ·Status: COMPLETED

Very Early Versus Delayed Etanercept in Patients With RA

NCT02433184 ·Status: COMPLETED ·Phase: PHASE4

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

NCT00256919 ·Status: COMPLETED ·Phase: PHASE2

Faecal Analyses in Rheumatoid Arthritis Therapy

NCT03775824 ·Status: COMPLETED

Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients

NCT00895050 ·Status: COMPLETED

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

NCT05375942 ·Status: COMPLETED

Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis

NCT04343378 ·Status: COMPLETED

Rheumatoid Arthritis Synovial Tissue Biopsy Study

NCT07000890 ·Status: COMPLETED ·Phase: NA

Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)

NCT02094326 ·Status: COMPLETED

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 ·Status: COMPLETED

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

NCT00929357 ·Status: COMPLETED

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

NCT01691014 ·Status: TERMINATED

A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

NCT06712628 ·Status: RECRUITING

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

Characterization of Non-Steroidal Anti-Inflammatory Drug (NSAID) Intake in Rheumatoid Arthritis (RA) Participants on Tocilizumab (RoACTEMRA®) Treatment

NCT03112213 ·Status: COMPLETED

Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy

NCT02531061 ·Status: COMPLETED ·Phase: NA

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).

NCT01577563 ·Status: COMPLETED

Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis

NCT05119452 ·Status: UNKNOWN ·Phase: NA